An extract of the first 100% of the full text is provided, because this article has no abstract. |
In the December 2004 issue of Arteriosclerosis, Thrombosis, and Vascular Biology, in the article entitled "2-Chlorohexadecanal Derived From Hypochlorite-Modified High-Density LipoproteinAssociated Plasmalogen Is a Natural Inhibitor of Endothelial Nitric Oxide Biosynthesis" by Marsche et al (Arterioscler Thromb Vasc Biol, 2004;24:23022306), the abbreviation of hypochlorous acid/hypochlorite in both the abstract and introduction of the article was erroneously listed as HOCl/Oce.
The abbreviation should have been set as HOCl/OCl.
The publisher regrets this error.
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |